Literature DB >> 35895584

Clinical Performance of Real-Time Polymerase Chain Reaction for Strongyloides stercoralis Compared with Serology in a Nonendemic Setting.

Christopher Swan1,2, Thuy Phan1,3, Genevieve McKew1,2.   

Abstract

Strongyloides stercoralis is a nematode endemic to subtropical and tropical regions that may cause asymptomatic carriage, peripheral eosinophilia, cutaneous, gastrointestinal, and pulmonary disease, or hyperinfection syndrome. Conventional diagnostic methods for strongyloidiasis include feces microscopy and culture, with low sensitivity in chronic infection due to the low helminth burden, and serology, which may be prone to false-negative results with immunocompromise and false-positive results with other infections and immunological disorders. We evaluated a laboratory-developed real-time polymerase chain reaction (RT-PCR), detecting the 18S SSU ribosomal RNA gene, compared with conventional diagnostic methods, using serology via ELISA as the gold-standard. The population studied included tertiary hospital inpatients and outpatients residing in a nonendemic area. Seven hundred fifty unfixed stool specimens submitted sequentially between 2014 and 2018 were tested for S. stercoralis via microscopy and RT-PCR. Agar plate culture (APC), Harada-Mori culture (HMC), and ELISA were performed in conjunction with 141, 135, and 177 of the specimens, respectively. RT-PCR yielded 13 positive and 730 negative results, with inhibition in seven specimens. ELISA yielded 53 positive, 18 equivocal, and 106 negative results. Results for direct diagnostic methods obtained after treatment with ivermectin were excluded from the performance analysis. Compared with ELISA, RT-PCR, microscopy, APC, and HMC exhibited sensitivities of 38%, 6%, 3%, and 0%, respectively, and specificities of 100%. Given the low sensitivities commensurate with testing a population with remote infection and thus low parasite burden, we recommend a combination of serological and molecular diagnostic testing to achieve the best balance of sensitivity and specificity.

Entities:  

Year:  2022        PMID: 35895584      PMCID: PMC9393460          DOI: 10.4269/ajtmh.21-1289

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  18 in total

1.  Management of chronic strongyloidiasis in immigrants and refugees: is serologic testing useful?

Authors:  Beverley-Ann Biggs; Sonia Caruana; Seema Mihrshahi; Damien Jolley; Jenne Leydon; Ley Chea; Sophy Nuon
Journal:  Am J Trop Med Hyg       Date:  2009-05       Impact factor: 2.345

2.  Seroprevalence of Strongyloides stercoralis in a South Australian Vietnam veteran cohort.

Authors:  Hany Rahmanian; Alexander C MacFarlane; Karen E Rowland; Lloyd J Einsiedel; Susan J Neuhaus
Journal:  Aust N Z J Public Health       Date:  2015-04-22       Impact factor: 2.939

3.  A retrospective study comparing agar plate culture, indirect immunofluorescence and real-time PCR for the diagnosis of Strongyloides stercoralis infection.

Authors:  Dora Buonfrate; Francesca Perandin; Fabio Formenti; Zeno Bisoffi
Journal:  Parasitology       Date:  2017-01-11       Impact factor: 3.234

4.  Analysis of the 18S ribosomal RNA gene of Strongyloides stercoralis.

Authors:  R A Putland; S M Thomas; D I Grove; A M Johnson
Journal:  Int J Parasitol       Date:  1993-02       Impact factor: 3.981

5.  Molecular phylogenetic analysis of the genus Strongyloides and related nematodes.

Authors:  Mark Dorris; Mark E Viney; Mark L Blaxter
Journal:  Int J Parasitol       Date:  2002-11       Impact factor: 3.981

6.  Serodiagnosis of human strongyloidiasis by an enzyme-linked immunosorbent assay.

Authors:  S M Carroll; K T Karthigasu; D I Grove
Journal:  Trans R Soc Trop Med Hyg       Date:  1981       Impact factor: 2.184

Review 7.  The laboratory diagnosis and follow up of strongyloidiasis: a systematic review.

Authors:  Ana Requena-Méndez; Peter Chiodini; Zeno Bisoffi; Dora Buonfrate; Eduardo Gotuzzo; José Muñoz
Journal:  PLoS Negl Trop Dis       Date:  2013-01-17

8.  Strongyloides seroprevalence before and after an ivermectin mass drug administration in a remote Australian Aboriginal community.

Authors:  Therese M Kearns; Bart J Currie; Allen C Cheng; James McCarthy; Jonathan R Carapetis; Deborah C Holt; Wendy Page; Jennifer Shield; Roslyn Gundjirryirr; Eddie Mulholland; Linda Ward; Ross M Andrews
Journal:  PLoS Negl Trop Dis       Date:  2017-05-15

Review 9.  Accuracy of molecular biology techniques for the diagnosis of Strongyloides stercoralis infection-A systematic review and meta-analysis.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Michela Cinquini; Mario Cruciani; Andrea Fittipaldo; Giovanni Giorli; Federico Gobbi; Chiara Piubelli; Zeno Bisoffi
Journal:  PLoS Negl Trop Dis       Date:  2018-02-09

10.  Diagnostic accuracy of five serologic tests for Strongyloides stercoralis infection.

Authors:  Zeno Bisoffi; Dora Buonfrate; Marco Sequi; Rojelio Mejia; Ruben O Cimino; Alejandro J Krolewiecki; Marco Albonico; Maria Gobbo; Stefania Bonafini; Andrea Angheben; Ana Requena-Mendez; José Muñoz; Thomas B Nutman
Journal:  PLoS Negl Trop Dis       Date:  2014-01-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.